157 related articles for article (PubMed ID: 2255674)
21. Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets.
Missaoui S; Ben Rhouma K; Yacoubi MT; Sakly M; Tebourbi O
J Diabetes Res; 2014; 2014():540242. PubMed ID: 25215302
[TBL] [Abstract][Full Text] [Related]
22. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
23. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
Liu IM; Chi TC; Cheng JT
Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
[TBL] [Abstract][Full Text] [Related]
24. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
25. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats & evidence for long-term relief of diabetes mellitus.
Dehghani GA; Sotoodeh M; Omrani GR
Indian J Med Res; 1999 Aug; 110():70-5. PubMed ID: 10573657
[TBL] [Abstract][Full Text] [Related]
26. Acute toxicity of vanadium compounds in rats and mice.
Llobet JM; Domingo JL
Toxicol Lett; 1984 Nov; 23(2):227-31. PubMed ID: 6334379
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of some chelating agents on distribution and excretion of vanadium in rats after prolonged oral administration.
Gómez M; Domingo JL; Llobet JM; Corbella J
J Appl Toxicol; 1991 Jun; 11(3):195-98. PubMed ID: 1918793
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
29. Vanadyl treatment normalizes submandibular salivary gland insulin-like immunoreactivity in streptozotocin-diabetic rats.
Deville de Périère D; Poucheret P; Egea JC; Gross R; Masiello P; Cros G; Serrano JJ; Ribes G
Horm Metab Res; 1998 Mar; 30(3):150-2. PubMed ID: 9566858
[TBL] [Abstract][Full Text] [Related]
30. The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.
Ozçelikay AT; Pekiner C; Ari N; Oztürk Y; Ozüari A; Altan VM
Diabetologia; 1994 Jun; 37(6):572-8. PubMed ID: 7926341
[TBL] [Abstract][Full Text] [Related]
31. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
32. Does the relief of glucose toxicity act as a mediator in proliferative actions of vanadium on pancreatic islet beta cells in streptozocin diabetic rats?
Pirmoradi L; Mohammadi MT; Safaei A; Mesbah F; Dehghani GA
Iran Biomed J; 2014 Jul; 18(3):173-80. PubMed ID: 24842144
[TBL] [Abstract][Full Text] [Related]
33. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
[TBL] [Abstract][Full Text] [Related]
34. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR
Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
[TBL] [Abstract][Full Text] [Related]
35. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
36. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
Sarangarajan R; Cacini W
Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
[TBL] [Abstract][Full Text] [Related]
37. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
39. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
40. Protective activity of pyruvate against vanadium-dependent cytotoxicity in Chinese hamster ovary (CHO-K1) cells.
Zwolak I; Gołębiowska D
Toxicol Ind Health; 2018 May; 34(5):283-292. PubMed ID: 29529943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
